Thus, we studied the effects of miR-198 on RCC development by transfecting the A498 and ACHN cells with scrambled mimic, miR-198, and miR-198 + FLAG-BIRC5 and measuring cell viability, apoptosis, and cell cycle experiments. The gene discussed is BIRC5; the disease is renal cell carcinoma.